Proteogenomic Signatures Analysis In Ovarian Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 17, 2022

Primary Completion Date

November 17, 2023

Study Completion Date

March 17, 2025

Conditions
Ovarian Cancer
Interventions
PROCEDURE

Tumor and blood sample

Analyzing proteogenomic profiles in order to find individual platinum-induced modifications on tumor tissue of HGSOC according to chemotherapy response score (CRS). Whole genome sequencing (WGS), transcriptomic (RNAseq) and proteomics analyses on OC tissue samples before and after a standard platinum-based chemotherapy will be carried out and correlated to clinical variables.

Trial Locations (1)

Unknown

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER